Herbal tea for prevention of primary placental insufficiency in patients with local immunodeficiency manifestations

FIELD: medicine.

SUBSTANCE: herbal tea for prevention of primary placental insufficiency in the patients suffering local immunodeficiency manifestations refers to medicine, namely obstetrics and gynaecology, and may be used in a complex preconception preparation of the women suffering fertility disorders, preferentially inflammatory ones, with clinical local immunodeficiency manifestations in maternity welfare centres. The declared tea contains morning and evening herbal teas.

EFFECT: herbal tea has a number of advantages: non-invasiveness, low price, ease-to-use, no side effects that enables higher effectiveness of prevention of primary placental insufficiency, avoided pregnancy and birth complications, improved perinatal indicators with low drug load on the woman's body before and during pregnancy.

3 ex

 

The invention relates to medicine, namely to obstetrics and gynecology, and can be used in complex pregravidarnoy preparation of patients with reproductive dysfunction predominantly inflammatory Genesis with clinical manifestations of local immunodeficiency syndrome (chronic endometritis, adnexitis, recurrent bacterial vaginosis, non-candidal vulvovaginitis, chronic tonsillitis).

The literature describes various ways pregravidarnoy training for women with problems of reproduction (infertility, habitual miscarriage syndrome fetal loss, chronic inflammation of the genitals) with the use of hormones, antibiotics, enzymes, immunomodulators, multivitamins, antiaggregants, physiotherapy and acupuncture. However, monotherapy is rarely yields positive results, and massive drug load leads to allergization of an organism, dysfunction of the immune system, which may interfere with implantation, formation full of fruit and trophoblast. Therefore, it remains relevant to the search and creation of new methods and drugs for pregravidarnoy preparation of patients with reproductive dysfunction, and preference is given to herbal medicine using herbal products.

Famous collection l of the drug plants (drink tea) No. 17, containing the red grass brush, clover, motherwort, yarrow, chamomile flowers, calendula, nettle leaves (manufacturer LLC "Universal Pharma, Gorno-Altaisk).

Famous collection helps to restore hormonal balance, helps to cope with premenstrual syndrome, normalizes the menstrual cycle, reduces the development of inflammation, symptoms of menopause, acts as an adjuvant in the treatment of infertility and gynecological diseases (uterine fibroids, endometriosis, polycystic ovarian, cervical erosion, adnexitis and so on).

The disadvantage of this collection is that existing Assembly clover contains a direct anticoagulant the dikumarina that can reduce blood clotting. Contraindications to the use of melilot drug also serves as arterial hypotension, which is often seen in young women planning to become pregnant, often in combination with moderate thrombocytopenia ([Electronic resource], http : //universalfarma.ru (accessed 24.01.2011)).

The closest achieved technical result is the collection of medicinal plants, representing vitamins phytocomplex "Artemida" (formula 1 + formula 2) JSC "Balm" (Biysk), used for the prevention of functional disorders of female genital SF is ture and therapy of several diseases as AIDS (chronic inflammatory processes, menstrual disorders, benign tumors - fibroids, endometriosis). The composition of the Formula 1 include: orthilia one-sided, red root, Comarum palustre, Valerian, yarrow. The composition of the Formula 2 include: orthilia one-sided, burdock root, calendula flowers, oregano, knotweed, St. John's wort, ascorbic acid and vitamin E (D. T.A., Lipatova O.A. "Mother and Child in Kuzbass". - 2010. - special. issue # 1. - P.27-29).

The disadvantages of this collection is welcome formulas strictly taking into account the phase of the cycle, as well as the presence of vitamin C, which can cause allergic reactions.

The authors suggest that the collection of medicinal plants for primary prevention of placental insufficiency with local manifestations of immunodeficiency, in which the phase pregravidarnoy preparation of patients with reproductive dysfunction arrest the clinical manifestations of local immunosuppression and menorrhagia.

The technical result of the proposed collection is to increase the effectiveness of primary prevention of placental insufficiency due to the preparation of the endometrium for pregnancy, which will reduce gestational complications in women with reproductive health problems, and therefore, perinatal loss and morbidity of newborns.

The technical result is achieved by the fact that the proposed collection updat the Executive holds for morning and evening purposes bergenia and shepherd's purse in the following ratio of components in the parts:

morning:

yarrow 1

bergenia 1

red root 1

stinging nettle 1

shepherd's purse 1

evening:

yarrow 1

bergenia 0,75

red root 0,5

stinging nettle 1

shepherd's purse 1

motherwort five-bladed 0,75

Declare the collection of medicinal plants for primary prevention of placental insufficiency with local manifestations of human immunodeficiency virus ("Collection-8" anti-inflammatory, hemostatic: certificate of state registration №U from 17.02.06 year; production LLC pharmaceutical plants "Galen") is intended for morning and evening use.

Cooking technology: medicinal plants in the briquettes, crushed by a special technology, are natural dried plants. Rapid manufacturing briquetting has the undeniable advantage: it does not lead to a weakening of the biological activity of herbs, extraction with boiling water at home is fast and efficient (without the water bath), excluded overdose.

Contraindications

The collection has an astringent effect that requires careful application and laxative diet when there is a tendency to constipation.

Part of the proposed collection of medicinal plants for the morning applied what I include medicinal plants in the following ratio of components in the parts:

yarrow 1

bergenia 1

red root 1

stinging nettle 1

shepherd's purse 1

Application of the proposed collection for morning application allows you to have anti-inflammatory, styptic and tonic effect, improves the condition of the body when inflammation of the genital and uterine bleeding.

Part of the proposed collection of medicinal plants evening wear includes medicinal plants in the following ratio of components in the parts:

yarrow 1

bergenia 0,75

red root 0,5

stinging nettle 1

shepherd's purse 1

motherwort five-bladed 0,75

Application of the proposed collection of medicinal plants for evening wear allows you to receive additional parasympathetic sedative effect.

Application of the proposed collection of medicinal plants in the morning and in the evening increases the range of pharmacological and therapeutic effects due to anti-inflammatory, immunomodulatory and hemostatic properties of herbs, helps to normalize lipid, carbohydrate and protein metabolism.

Yarrow increases blood clotting, resulting in the shortening of the time rekaltsifikatsii oxalate plasma, the increase in t is lerotholi plasma to heparin, the decrease in heparin-time. The herbal preparations activate the effect of fibrin, but never lead to the formation of blood clots. Based hemostatic effect of yarrow is the increase in the number of platelets and shortening time to stop bleeding. The content in the plant tannins, essential oils and chamazulene due to anti-inflammatory, antibacterial, anti-allergic properties of yarrow. Used in inflammatory processes in the genital organs, uterine bleeding.

Bergenia has anti-inflammatory, astringent, styptic and antibacterial properties due to the presence of tannins. Strengthens capillary walls and helps local vasoconstrictor effect. Used in hemorrhagic syndrome.

Red root has anti-inflammatory, antiexudative, Vasoprotectives, antioxidant, antispasmodic, vasodilator, tonic effect. The effect of the red root is due to the properties contained in the plant flavonoids, tannins, coumarins, triterpene saponins, amino acids and other biologically active compounds (quercetin, kaempferol, avicularin, hyperoside, catechins). Red root has a high vitamin P activity: strengthens tenki capillaries, reduces their permeability, has a mild corrective effect on the immune system. Set its ability to stimulate the Central nervous system, effectively relieve fatigue, improve physical endurance.

Nettle has pronounced hemostatic properties that are associated with the presence in the leaves of the plant vitamin K, which stimulates the liver one of the most important factors of the blood coagulation prothrombin. Dosage forms of nettle have anti-inflammatory and vasoconstrictor effects. The chlorophyll contained in large quantities in the plant, has a stimulating and tonic effect, increases basal metabolic rate, and increases muscle tone of the uterus and intestines, stimulates granulation and epithelization of the affected tissues. The amount of active substances, mainly vitamins and iron salts, normalize the body's lipid metabolism.

Herbal medicines shepherd's purse have a marked anti-inflammatory and hemostatic effect, especially when haemorrhage, caused by the insufficient formation of fibrin due to the high content of tannins. In addition, they increase the contractility of the smooth muscles of the uterus and bowel movements.

Motherwort has sedative properties, regulates the functionality is the emotional state of the Central nervous system. Has a beneficial effect on carbohydrate and fat metabolism, reduces the level of glucose, lactic and pyruvic acids, cholesterol, total lipids in the blood, normalizes the protein metabolism. In addition, the plant has antispasmodic, anticonvulsant action.

The composition of the proposed collection of medicinal plants, as the ratio of herbs, was chosen experimentally to achieve the most effective application to pregravidarnoy stage with the aim of primary prevention of placental insufficiency in women with reproductive dysfunction, and local manifestations of immunodeficiency, which reduces the frequency of pregnancy complications and adverse perinatal outcomes. The claimed medicinal plants can be used both internally and topically vaginally.

Declare the collection of medicinal plants for primary prevention of placental insufficiency with local manifestations of immunodeficiency apply (morning, morning, evening - night) as follows: 1 briquette add 0.5-1 Cup boiling water, infuse for 5-10 minutes, and the "water bath" is not required. Take 0.5-1 Cup of warm infusion for 30 minutes before eating. Drunk residue enhances the action. Daily dose of 2 briquette: 1 briquette - in the morning (morning), 1 briquette - in the evening (evening). Recommended courses of reception: 1-3 months is a - 1-2 times per year.

The claimed medicinal plants can be used not only inside, but also locally in the form of douches and baths with persistent nonspecific and candidal vaginitis, bacterial vaginosis. In this case, the dosage is 2 briquette to 1 Cup of boiling water. Boil for 1-2 minutes Exposure time is 15-20 minutes to Apply 1-2 times a day for 10-14 days.

Clinical examples

Example 1. Patient C., 33 years. History: 1 urgent delivery. Chronic endometritis due to long-term wearing of the intrauterine device (10 years). Uterine fibroids are clinically insignificant. Previously for the treatment of chronic endometritis received antibiotic therapy with doxycycline, trichopol. During the test tubes are permeable, ultrasound chronic endometritis. Was offered the claimed medicinal plants, which the patient received 3 cycles. After a full course of preventive therapy in pregnancy, which was uneventful and ended urgent delivery the male fetus weighing 3800 grams, Apgar 8-9. Discharged from the hospital to home.

Example 2. Patient D., aged 27. History: menstrual function type hyperelementary on the Navy background. After removal of intrauterine contraceptive pregnancy that terminated spontaneously in the early stages of Gestas is I. Histological diagnosis: anembryonic. Surveyed: ovulatory menstrual cycle, harmonogram normal tubes are permeable, husband fertile. Was offered the claimed medicinal plants, which the patient received 2 cycles. On a background of reception of pregnancy, which ran physiologically and ended urgent delivery of the fetus is female, weighing 3600 grams, Apgar 8-8 points. Discharged from the hospital to home.

Example 3. The patient M, 38 years. History 1 births and 3 spontaneous abortion in the first trimester of pregnancy. When examination revealed chronic endometritis, nonspecific vaginitis. Specific infections are excluded. Assigned programadora complex therapy of the proposed collection of medicinal plants inside and topically in the form of trays in combination with additional immunotherapy drug "transfer factor". The treatment in the second round of the proposed collection of medicinal plants of pregnancy, which ran physiologically and ended urgent delivery the male fetus weighing 3400 grams, Apgar 8-8 points, was discharged from the hospital to home.

Declare the collection of medicinal plants for primary prevention of placental insufficiency with local manifestations of immunodeficiency tested in 36 pregnant women with reproductive dysfunction, n is bludovice in the clinic GOU VPO agmu University "Consultative-diagnostic center" activities.

All women previously underwent a complete clinical examination. The average age was 26.4±4.3 years. Burdened obstetric anamnesis had 33 women: medical abortion 27.8%, spontaneous miscarriages - 19.4%, chronic inflammation of the genitals - in 22.2%, hyperprolinemia - in 5.6% of cases. Extragenital disease patients in 94.4% of cases. The effectiveness of the exchange rate of the serial reception in the complex pregravidarnoy preparation of patients with problematic reproduction has resulted in the disappearance of clinical symptoms of non-specific vaginitis in 90% of cases; the relief of symptoms of chronic endometritis and hyperprolinemia in 100% of cases; the occurrence of pregnancy in women with reproductive disorders on the background of gynecological diseases in 52,8% of cases.

Thus, the claimed medicinal plants for primary prevention of placental insufficiency in pregravidarnoy training in women with reproductive disorders, inflammatory Genesis with local manifestations of immunodeficiency to contribute to the rehabilitation of chronic infections of the genitals and pregnancy. Full implantation and placenta formation leads to physiological course of pregnancy with the birth of a healthy donose the children and avoids reproductive and perinatal losses.

In addition, the claimed medicinal plants has several other advantages: non-invasive, low cost, easy to use, no side effects, which allows to increase the effectiveness of primary prevention of placental insufficiency, to avoid complications of pregnancy and childbirth, to improve perinatal indicators at low drug load on a woman before pregnancy and during pregnancy.

The collection of medicinal plants for primary prevention of placental insufficiency in women with local manifestations of immunodeficiency, including morning and evening charges of medicinal plants in the following ratio of components in the parts:
morning:

yarrow1
bergenia1
red root1
stinging nettle1
shepherd's bag1

evening:
yarrow1
bergenia0,75
red root0,5
stinging nettle1
shepherd's bag1
motherwort five-bladed0,75



 

Same patents:

FIELD: medicine.

SUBSTANCE: invention refers to veterinary medicine. A method of treating (therapy) subclinical mastitis in cows involves the introduction of the St. John's wort tea 15 ml in the involved lobes of mammary gland three times every 24 hours combined with the single intramuscular introduction of the stress corrector Ligfol 5 ml.

EFFECT: invention provides higher clinical effectiveness.

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmacology and represents an agent for fibromyalgia containing pilocarpine or pilocarpine hydrochloride, and a pharmaceutically acceptable carrier wherein a daily dose of pilocarpine or pilocarpine hydrochloride makes 0.1 mg to 1000 mg.

EFFECT: invention provides effective therapy of fibromyalgia symptoms.

5 cl, 3 ex, 1 tbl, 3 dwg

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medicine and pharmaceutical industry, and concerns a composition having a complex effect on the vascular endothelium. The composition contains L-arginine or L-citrulline, and an arginase inhibitor in a solid dosage form. The composition possess an endothelial protective, vasodilating and angioprotective effect. The synergetic effect is provided by combining NO donators and the arginase inhibitors in the retard form.

EFFECT: preparing the composition possessing the complex effect on the vascular endothelium.

7 cl, 5 ex, 54 tbl, 2 dwg

FIELD: medicine, pharmaceutics.

SUBSTANCE: group of inventions refers to medicine, and may be used for the use of testosterone and 5-HT1A agonist for preparing a drug for treating sexual dysfunction. Said drug is used as required wherein testosterone is released 3.5-5.5 hours before sexual activity, and 5-HT1A agonist is introduced so that effects of the peak amounts of said substances are partially overlapped. What is also presented is the use of testosterone, PDE5 inhibitor and 5-HT1A agonist for preparing the drug for treating sexual dysfunction. There are also presented pharmaceutical compositions and kits.

EFFECT: group of inventions provides reducing the blood testosterone and 5-HT1A agonist levels to physiological values that promotes treating sexual dysfunction both in males, and in females.

17 cl, 4 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: group of inventions refers to medicine, and may be used for the use of testosterone and 5-HT1A agonist for preparing a drug for treating sexual dysfunction. Said drug is used as required wherein testosterone is released 3.5-5.5 hours before sexual activity, and 5-HT1A agonist is introduced so that effects of the peak amounts of said substances are partially overlapped. What is also presented is the use of testosterone, PDE5 inhibitor and 5-HT1A agonist for preparing the drug for treating sexual dysfunction. There are also presented pharmaceutical compositions and kits.

EFFECT: group of inventions provides reducing the blood testosterone and 5-HT1A agonist levels to physiological values that promotes treating sexual dysfunction both in males, and in females.

17 cl, 4 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: group of inventions refers to medicine, and may be used for the use of testosterone and 5-HT1A agonist for preparing a drug for treating sexual dysfunction. Said drug is used as required wherein testosterone is released 3.5-5.5 hours before sexual activity, and 5-HT1A agonist is introduced so that effects of the peak amounts of said substances are partially overlapped. What is also presented is the use of testosterone, PDE5 inhibitor and 5-HT1A agonist for preparing the drug for treating sexual dysfunction. There are also presented pharmaceutical compositions and kits.

EFFECT: group of inventions provides reducing the blood testosterone and 5-HT1A agonist levels to physiological values that promotes treating sexual dysfunction both in males, and in females.

17 cl, 4 ex

FIELD: medicine.

SUBSTANCE: invention relates to field of medicine, namely to urology, and can be used for treatment of patients with chronic infectious prostatitis. For this purpose, suppositories, containing 0.75 g of dense extract of licorice root on hydrophilic base with polyethylene glycol 6000 and polyethylene glycol stearate are introduced intrarectally, in dose 1 suppository with weight 2.25 g 2 times per day, daily. Course of treatment constitutes 10 days.

EFFECT: method provides efficient treatment due to antibiotic anti-inflammatory hormone-modulating and restoring sexual function action of suppositories.

6 tbl

FIELD: medicine.

SUBSTANCE: method involves simulating gestosis in Wistar rats by the daily intraperitoneal introduction of L-nitro-arginine-methyl ester 25 mg/kg for 14th to 20th day of pregnancy. The simulated pathology is corrected by the subcutaneous introduction of recombinant erythropoietin 50 IU/kg on the 7th, 10th, 13th, 16th, 19th day of pregnancy.

EFFECT: method provides correction of systemic endothelial dysfunction accompanying gestosis in the specific experimental environment.

1 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely obstetrics and gynaecology, and may be used for treating early miscarriage in females with primary hyperprolactinemia. That is ensured by prescribing a sparing regimen combined with the administration of dufaston. It is added with prescribing the preparation dostinex 0.125 mg - 0.250 mg at bedtime to a pregnant woman 1-2 times a week to the 10-12th week of pregnancy.

EFFECT: method provides higher clinical effectiveness, reduced side effects and complications.

3 ex

FIELD: medicine.

SUBSTANCE: ADMA-like gestosis model is experimentally reproduced in laboratory pregnant Wistar rats by the daily intraperitoneal introduction of L-nitro-arginine-methyl ester 25 mg/kg for 7 days. The endothelial dysfunction is corrected by the vitamine-mineral preparation 'Complivit Trimestrum Trimester 3' which with underlying simulation is introduced intragastrically in a dose of 0.084 tablet/kg/day for 7 days.

EFFECT: method provides effective endothelial dysfunction correction in pregnant females ensured by an endothelioprotective effect of vitamins under specified experimental conditions and dosages.

1 ex

FIELD: medicine.

SUBSTANCE: invention refers to veterinary medicine. A method of treating (therapy) subclinical mastitis in cows involves the introduction of the St. John's wort tea 15 ml in the involved lobes of mammary gland three times every 24 hours combined with the single intramuscular introduction of the stress corrector Ligfol 5 ml.

EFFECT: invention provides higher clinical effectiveness.

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutical industry, particularly to an agent possessing hepatoprotective activity and an ability to normalise the hepatic function. The use of a ground elevated part of Saussurea plants or an aqueous or aqueous-alcoholic or supercritical fluid extract of the elevated part of Saussurea plants as the agent possessing hepatoprotective activity and the ability to normalise the hepatic function.

EFFECT: agent possess manifested hepatoprotective activity and the ability to normalise the hepatic function.

3 cl, 1 tbl, 5 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutical and cosmetic industry, particularly to a method for preparing borneol. The method for preparing borneol from a hydrodistillate of a lipid portion of fir wood green extract involving saponification of the hydrodistillate in an alcohol solution of alkali, heating, stripping of alcohol and a portion of volatile ingredients, washing in hot still bottom water, separation of still bottom from an aqueous layer, crystallisation of borneol, filtration, washing in an organic solvent, re-crystallisation from mixed ethylacetate and petroleum benzene under certain conditions.

EFFECT: method is used to prepare borneol with the content of the main ingredient >99%; the method promotes a higher degree of using the feedstock.

1 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to phthisiology, and may be used for treating tuberculosis complicated by intolerance to chemotherapy. That is ensured by prescribing the product "Cedar Proteins" 15.0 g of powder dissolved in boiled water 150.0-200.0 ml once a day 1.5-2 h after breakfast for 21 days with underlying standard anti-tuberculosis chemotherapy.

EFFECT: use of the given method of treating provides improving tolerance to the anti-tuberculosis therapy and reducing the symptoms of tuberculous intoxication.

1 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutics and concerns influenza virus reproduction inhibitors - the A/California/07/09 (H1N1)v strain representing (R)-usnic acid (1) and an oxidated derivative of (S)-usnic acid (2): .

EFFECT: inhibitors possess high inhibitory activity.

4 ex, 1 tbl

FIELD: medicine.

SUBSTANCE: invention refers to pharmaceutical, food and cosmetic industry, particularly to a method for preparing a shelf fungus extract. The method for preparing a shelf fungus extract involving soaking of ground shelf fungus in an aqueous solution containing 5-15% dimethylsulphoxide and 2-8% sodium hydroxide under certain conditions, filtration and removal of the aqueous solution followed by staged extraction of the prepared raw material in water, filtration of the extract to provide a first degree of extraction and pulp to be extracted to provide a second degree of extraction, and merge of the extracts.

EFFECT: method provides producing the extract of high yield extract substances, polyphenols and high antioxidant activity.

1 tbl, 2 ex

FIELD: medicine.

SUBSTANCE: invention refers to cosmetology and concerns a hair conditioning composition containing: (a) 10 to 90 wt % of one or more ingredients specified in higher alcohols, higher fatty acids and their derivatives, (b) 5 to 35 wt % of a cationic surfactant, and (c) a polyatomic alcohol and/or polyethylene glycol having a melting point 155°C or less; wherein endothermic peak of the gel formed by the ingredients (a) and (b) in the composition makes 50°C or more as measured by a differential scanning calorimetre (DSC), the water content makes 10 wt % or less, and the molar ratio of the ingredient (a) to the ingredient (b) makes 2.5 to 6.0.

EFFECT: invention provides the easy-care hair conditioning composition with the very low water content.

7 cl, 6 tbl, 3 ex

FIELD: medicine.

SUBSTANCE: invention refers to cosmetology and concerns a hair conditioning composition containing: (a) 10 to 90 wt % of one or more ingredients specified in higher alcohols, higher fatty acids and their derivatives, (b) 5 to 35 wt % of a cationic surfactant, and (c) a polyatomic alcohol and/or polyethylene glycol having a melting point 155°C or less; wherein endothermic peak of the gel formed by the ingredients (a) and (b) in the composition makes 50°C or more as measured by a differential scanning calorimetre (DSC), the water content makes 10 wt % or less, and the molar ratio of the ingredient (a) to the ingredient (b) makes 2.5 to 6.0.

EFFECT: invention provides the easy-care hair conditioning composition with the very low water content.

7 cl, 6 tbl, 3 ex

FIELD: medicine.

SUBSTANCE: invention refers to cosmetology and concerns a hair conditioning composition containing: (a) 10 to 90 wt % of one or more ingredients specified in higher alcohols, higher fatty acids and their derivatives, (b) 5 to 35 wt % of a cationic surfactant, and (c) a polyatomic alcohol and/or polyethylene glycol having a melting point 155°C or less; wherein endothermic peak of the gel formed by the ingredients (a) and (b) in the composition makes 50°C or more as measured by a differential scanning calorimetre (DSC), the water content makes 10 wt % or less, and the molar ratio of the ingredient (a) to the ingredient (b) makes 2.5 to 6.0.

EFFECT: invention provides the easy-care hair conditioning composition with the very low water content.

7 cl, 6 tbl, 3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical and cosmetic industry, and represents a cosmetic or pharmaceutical composition which contains a hydrophilic external phase, at least one cosmetic and/or pharmaceutical active ingredient, and at least one carrier for the active ingredient. The carrier forms such structures which contain at least two layers of plate-type double membrane sandwiched one above the other with a layer of an internal phase arranged between the adjoining parallel layers of the double membrane. The active ingredient is distributed in the layer of the double membrane and in the layer of the internal phase so that the layer of the internal phase contains the active ingredient within the range of concentrations 2 wt % to 98 wt %, and the layer of the double membrane contains the active ingredient within the range of concentrations 98 wt % to 2 wt % respectively in relation to the full concentration of the active ingredient, and the external phase does not contain or contains a very small amount of the active ingredient.

EFFECT: invention provides creating the high-efficacy pharmaceutical or cosmetic agent.

72 cl, 15 ex, 3 dwg

FIELD: medicine.

SUBSTANCE: invention refers to veterinary medicine. A method of treating (therapy) subclinical mastitis in cows involves the introduction of the St. John's wort tea 15 ml in the involved lobes of mammary gland three times every 24 hours combined with the single intramuscular introduction of the stress corrector Ligfol 5 ml.

EFFECT: invention provides higher clinical effectiveness.

Up!